Part A: Hemodialysis-Clinical Management and Follow Up

  • Barbara G. Delano


World wide, more than 500,000 patients are treated for End Stage Renal Disease. While transplantation and peritoneal dialysis are therapies to be considered, hemodialysis remains the mainstay of treatment. The tremendous and rapid growth of this therapy, which was first reported for the treatment of chronic renal failure in 1960 (1) has made it imperative for all health care providers to become familiar with the care of the dialysis patient. Most of the topics covered in this chapter are dealt with in greater detail in the rest of this book. The following will cover some practical aspects of how to initiate and monitor dialysis in routine and high risk patients


Systemic Lupus Erythematosus Multiple Myeloma Peritoneal Dialysis Renal Replacement Therapy Sickle Cell Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Scribner BH, Buri R, Caner JEZ, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent dialysis: a preliminary report. Trans Am Soc Artif Intern Organs 6: 114, 1960PubMedGoogle Scholar
  2. 2.
    Malangone JM, Abuelo JG, Pezzullo JC, Lund K, McGloin CA: Clinical and laboratory feature of patients with chronic renal disease at the start of dialysis. Clin Nephrol 31: 77, 1989PubMedGoogle Scholar
  3. 3.
    Bonomini V: On optimal dialysis. Kidney Int 7(Suppl 3): 365S, 1976Google Scholar
  4. 4.
    Bonomini V: Long term early dialysis. (Abstract) 3rd Int Conf Uremia Capri 7, 1980Google Scholar
  5. 5.
    Bonomini V: Early dialysis up-dated. Int J Artif Organs 4:54, 1981PubMedGoogle Scholar
  6. 6.
    Bonomini V, Baldrati L, Stefoni S: Comparative cost/benefit analysis in early and late dialysis. Nephron 33: 1, 1983PubMedCrossRefGoogle Scholar
  7. 7.
    Scribner BH: A critical comment. Nephron 16: 100, 1976Google Scholar
  8. 8.
    Ratcliffe PJ, Philips RE, Oliver, DV: Late referral for maintenance dialysis. Br Med J 288: 441, 1983Google Scholar
  9. 9.
    Binik YM, Devins GM, Barre PE et al.: Live and learn: patient education delays the need to initiate rerial replacement therapy in end-stage renal disease. J Nervous Mental Dis 181:371, 1993Google Scholar
  10. 10.
    Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venipuncture and a surgically created arterio-venous fistula. N Engl J Med 275: 1089, 1966PubMedCrossRefGoogle Scholar
  11. 11.
    Kherlakian GM, Rodersheimer LR, King LR: Comparison of autogenous fistula versus expanded polytetrafluoroethyene graft fistula for angioaccess in hemodialysis. Am J Surg 152:238, 1986PubMedGoogle Scholar
  12. 12.
    De Moor B, Vanholder R, Ringoir S: Subclavian vein hemodialysis catheters: advantages and disadvantages. Artif Organs 18: 293, 1994PubMedGoogle Scholar
  13. 13.
    Pascua LJ: Vascular access update. Trans Am Soc Artif Intern Organs 25: 526, 1979PubMedGoogle Scholar
  14. 14.
    Arana VA: Percutaneous femoral vein catheterization in patients requiring hemodialysis. J Urol 106: 492, 1971PubMedGoogle Scholar
  15. 15.
    Barth RH: High-Flux hemodialysis: overcoming the tyranny of time. Contrib Nephrol 102: 73, 1993PubMedGoogle Scholar
  16. 16.
    Barth RH, Rubin JE, Berlyne GM: Very high blood flow is safe and effective in hemodialysis. ASAIO Abstr 17: 58, 1988Google Scholar
  17. 17.
    Ronco C, Feriani M, La Greca G: Hemodynamic response to high blood flows and ultrafiltration modeling during short dialysis. Kidney Int 37: 317, 1990Google Scholar
  18. 18.
    Chanard J, Bindi P, Lavaud S, Toupance O, Malcut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. Br Med J 298: 867, 1989Google Scholar
  19. 19.
    Miura Y, Ishiyama T, Inomata A et al.: Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 60: 268, 1992PubMedGoogle Scholar
  20. 20.
    Van Ypersele DO, Strichou C, Jadoul M, Malghem J, Maldague B, Jamart J: The working party on dialysis-related amyloidosis. Kidney Int 39: 1012, 1991Google Scholar
  21. 21.
    Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: results of a clinical trail comparing polysulfone with cuprophan. Kidney Int 40: 714, 1991Google Scholar
  22. 22.
    Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis-associated disease in the United States, 1989. Trans Am Soc Artif Intern Organs 37: 97, 1991Google Scholar
  23. 23.
    Collins AJ, Keshaviah P: High efficiency therapies for clinical dialysis, in Clinical Dialysis, 2nd Edition, edited by Nissenson AR, Fine RN, Gentile DE, Nonvalk, Appleton & Lange, 1990, p 687Google Scholar
  24. 24.
    Civati G, Guastone C, Teatini U et al.: High flux acetate hemodialysis: a single-centre experience. Nephrol Dial Transpl 6(Suppl 2): 75, 1991Google Scholar
  25. 25.
    Gordon SM, Oettinger CW, Bland LA et al.: Pyrogenic reactions in patients receiving conventional, high efficiency or high flux hemodialysis treatments with bicarbonate dialysate containing high concentration of bacteria and endotoxin. J Am Soc Nephrol 2: 1436, 1992PubMedGoogle Scholar
  26. 26.
    Pegus DA, Oettinger CW, Bland LA et al.: A prospective study of pyrogenic reaction in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 3: 1002, 1992Google Scholar
  27. 27.
    Sztajzel J, Ruedin P, Stoermann C et al.: Effects of dialysate composition during hemodialysis on left ventricular function. Kidney Int 41: 60, 1993Google Scholar
  28. 28.
    Gurudev, KC, Pathak V, Prabhakar, KS, Bhaskar S, Prakash KC, Mani MK: Short term study of relative merits of acetate and bicarbonate dialysis. J Assoc Physicians of India 39: 921, 1991Google Scholar
  29. 29.
    Saha H, Pietila K, Mustonen J, Pastemack A, Morsky P: Acute effect of dialysate calcium concentration and intravenous Vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients. Clin Nephrol 38: 145, 1992PubMedGoogle Scholar
  30. 30.
    Slatopolsky E, Weerts C, Norwood K: Long term effects of calcium carbonate and 0.5 mEq/1 calcium dialysate on mineral metabolism. Kidney Int 36: 897, 1989PubMedGoogle Scholar
  31. 31.
    Valporean ML, Van Stone JC: Dialysate magnesium. Semin Dial 6: 46, 1993Google Scholar
  32. 32.
    Markell, MS, Altura BA, Sam Y et al.: Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis. ASAIO J 39: 801, 1993Google Scholar
  33. 33.
    Altura BT, Brust M, Bloom S, Altura BM: Magnesium dietary intake modulates blood lipids and atherogenesis. Proc Natl Acad Sci USA 87: 1840, 1990PubMedGoogle Scholar
  34. 34.
    Kennedy AC, Linton AL, Eaton J: Urea levels in cerebrospinal fluid after hemodialysis. Lancet 1: 410, 1962PubMedGoogle Scholar
  35. 35.
    Arieff A: Dialysis Disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 45: 629, 1994PubMedGoogle Scholar
  36. 36.
    Leonard A, Shapiro FL: Subdural hematoma in regularly hemodialylzed patients. Ann Intern Med 82: 650, 1975PubMedGoogle Scholar
  37. 37.
    Van Stone JC, Carey J, Meyer R Murrin C: Hemodialysis with glycerol containing dialysate. Trans Amer Soc Artif Intern Organs 2: 119, 1979Google Scholar
  38. 38.
    Rosa AA, Shideman J, McHugh R, Duncan D, Kjellstrand CM: The importance of osmolality fall and ultrafiltration rate on hemodialysis side effects. Nephron 27: 134, 1981PubMedGoogle Scholar
  39. 39.
    Goldwaser P, Mittman N, Antignani A et al.: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3: 1613, 1993Google Scholar
  40. 40.
    Hakim RM, Depner TA, Parker TF: Adequacy of hemodialysis. Am J Kidney Dis 21: 567, 1993Google Scholar
  41. 41.
    Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH: Mortality and duration of hemodialysis treatment. JAMA 265: 871, 1991PubMedGoogle Scholar
  42. 42.
    Charra B: Does empirical long slow dialysis result in better survival? If so, how and why? ASAIO J 39: 819, 1993PubMedGoogle Scholar
  43. 43.
    Owens WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001, 1993Google Scholar
  44. 44.
    Lowrie EG, Liu NL: Death risk of hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458, 1990PubMedGoogle Scholar
  45. 45.
    Blagg CR: Adequacy of dialysis. Am J Kidney Dis 2: 218, 1984Google Scholar
  46. 46.
    Babb AL, Scribner BH: Quantitative description of dialysis treatment I. A dialysis index. Kidney Int 7(Suppl 2): 23S, 1975Google Scholar
  47. 47.
    Ahmad S, Babb AL, Mulutinovic J, Scribner BH: Effect of residual renal function on minimal dialysis requirements. Proc Euro Dial Tranpl Assoc 16: 107, 1979Google Scholar
  48. 48.
    Keshaviah P, Collins A: Rapid high efficiency bicarbonate hemodialysis. Trans Am Soc Artif Intern Organs 32: 17, 1986Google Scholar
  49. 49.
    Basile C, Casino F, Lopez T: Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 15: 40, 1990PubMedGoogle Scholar
  50. 50.
    Flanigan MJ, Fangman J, Lim VS: Quantitating hemodialysis: a comparison of three kinetic models. Am J Kidney Dis 17: 295, 1991PubMedGoogle Scholar
  51. 51.
    Teschan PE: Clinical estimates of treatment adequacy. Artif Organs 10: 201, 1986PubMedGoogle Scholar
  52. 52.
    Read DJ, Feest TG, Holmon RH: Vibratory sensory threshold: A guide to adequacy of dialysis. Proc Eur Dial Transpl Assoc 19: 253, 1983Google Scholar
  53. 53.
    Phillips LH, Williams FH: Are nerve conduction studies useful for monitoring the adequacy of renal dialysis? Muscle and Nerve 16: 970, 1993PubMedGoogle Scholar
  54. 54.
    De Palma JR: Adequate hemodialysis schedule. N Engl J Med 285: 353, 1972Google Scholar
  55. 55.
    Hakim RM, Lazarus JM: Medical aspects of hemodialysis. in The Kidney, edited by Brenner BM, Rector FC, Philadelphia, Saunders, 1986, p 1791Google Scholar
  56. 56.
    Neu S, Kjellstrand CM: Stopping long term dialysis. An empirical study of withdrawal of life supporting treatment. N Engl J Med 314: 14, 1986PubMedCrossRefGoogle Scholar
  57. 57.
    Port FK, Wolfe RA, Hawthorne VM, Ferguson CW: Discontinuation of dialytic therapy as a cause of death. Am J Nephrol 9: 145, 1989PubMedGoogle Scholar
  58. 58.
    Mailloux LU, Bellucci AG, Napolitano B, Mossey RT, Wilkes BM, Bluestone PA: Death by withdrawal from dialysis: a 20 year clinical experience. J Am Soc Nephrol 3: 1631, 1993PubMedGoogle Scholar
  59. 59.
    Kjellstrand CM, Dolan JM, Rachels J, Epstein FH: Is one allowed to stop artificial organs allowing patients to die? Trans Am Soc Artif Intern Organs 32: 671, 1986PubMedGoogle Scholar
  60. 60.
    Holley JL, Nespor S, Rault R: The effects of providing chronic hemodialysis patients written material on advanced directives. Am J Kidney Dis 22: 413, 1993PubMedGoogle Scholar
  61. 61.
    Sekkarie MA, Port KF, Wolfe RA et al.: Recovery from end stage renal disease. Am J Kidney Dis 15: 61, 1990PubMedGoogle Scholar
  62. 62.
    Mitchell HC, Graham RM, Pettinger WA: Renal function during long treatment of hypertension with minoxidil. Ann Intern Med 93: 676, 1980PubMedGoogle Scholar
  63. 63.
    Bacon BR, Ricanati ES: Severe and prolonged renal insufficiency. Reversal in a patients with malignant hyper-tension. JAMA 239: 1159, 1978PubMedGoogle Scholar
  64. 64.
    Maxey RW, Rao TKS, Manis T, Delano BG, Friedman EA: Return of renal function after commencing maintenance hemodialysis. Proc Clin Dial Transpl Forum 5:12, 1975Google Scholar
  65. 65.
    Steen VD, Constantino JP, Shapiro AP, Medsger TA: Outcome of renal crisis in systemic sclerosis: relation of availability of angiotensin converting enzyme inhibitors. Ann Intern Med 113: 352, 1990PubMedGoogle Scholar
  66. 66.
    Kimberly RP, Lockshin MD, Sherman RL, Mouradian J, Saal S: Reversible end-stage lupus nephritis. Analysis of patients able to discontinue dialysis. Am J Med 74: 361, 1983PubMedGoogle Scholar
  67. 67.
    Misani R, Tiraboschi G, Mingardi G, Mecca G: Management of myeloma kidney: an anti-light chain approach. Am J Kidney Dis 10: 28, 1987Google Scholar
  68. 68.
    Pichette V, Querin S, Desmeules M, Ethier J, Copleston P: Renal function recovery in end-stage renal disease. Am J Kidney Dis 22: 398, 1993PubMedGoogle Scholar
  69. 69.
    Richter M, Porile JL: Preservation of vascular access. J Am Soc Nephrol 4: 997, 1993PubMedGoogle Scholar
  70. 70.
    Esbach JW, Adamson JW: Recombinant human erythro-poietin. Implications for Nephrology 9: 203, 1989Google Scholar
  71. 71.
    Eschbach JW: Erythropoietin: the promise and the facts. Kidney Int 45(Suppl 4): 70S, 1994Google Scholar
  72. 72.
    Ng YY, Chow, MP, Lou JY et al.: Resistance to erythropoietin: immunohemolytic anemia induced by residual formaldehyde in dialyzers. Am J Kidney Dis 21: 213, 1993PubMedGoogle Scholar
  73. 73.
    Rault R, Nespor S, Holley J: Safety and efficacy of 500 mg of iron-dextran as a single IV infusion in patients on chronic dialysis. Abs ASAIO 23: 74, 1994Google Scholar
  74. 74.
    Amerling R, Levin NW: Erythropoietin update. The Kidney 26: 1, 1992Google Scholar
  75. 75.
    Van Wyck DB, Stivelman JC, Ruiz J, Kielin LF, Katz, MA, Ogden DA: Iron stores in patients receiving erythropoietin for dialysis associated anemia. Kidney Int 35: 712, 1989PubMedGoogle Scholar
  76. 76.
    Koury NJ: Investigating erythropoietin resistance. N Engl J Med 238: 205, 1993Google Scholar
  77. 77.
    Ra DS, Shah M, Muhinyo R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171, 1993Google Scholar
  78. 78.
    Berersab A: Optimizing epoetin therapy in ESRD. The case for subcutaneous administration. Am J Kidney Dis 22: 23, 1993Google Scholar
  79. 79.
    Ashi NI, Paganini EP, Wilson JM: Erythropoietin: Intravenous versus subcutaneous administration. A review of the literature. Am J Kidney Dis 22(Suppl 1): 23, 1993Google Scholar
  80. 80.
    Goldberg AP, Hagberg JM, Delmez, JA, Haynes ME: Metabolic effects of exercise training in hemodialysis patients. Kidney Int 18: 754, 1980PubMedGoogle Scholar
  81. 81.
    Goodman WG, Coburn JW, Ramirez JA, Slatopolsky E, Salusky IB: Renal osteodystrophy in adults and children. in A Primer of Metabolic Bone Disease, edited by Favus MJ, New York, Raven Press, 1993, p 304Google Scholar
  82. 82.
    Quarles DL, Davidal GA, Schwab SI, Bartholomey DW, Lobaugh B: Oral calcitriol and calcium: effective therapy for uremic hyperparathyroidism. Kidney Int 34: 840, 1988PubMedGoogle Scholar
  83. 83.
    McCarthy, JT, Milliner DS, Johnson WJ: Clinical experience with desferrioxamine in dialysis patients with aluminum toxicity. Quart J Med 74: 257, 1990PubMedGoogle Scholar
  84. 84.
    Quarles DL, Yohay Da, Carroll BA et al.: Prospective double blind placebo controlled trial of oral versus IV calcitriol in the treatment of hyperparathyroidism in ESRD. J Am Soc Neprol 4: 718, 1993Google Scholar
  85. 85.
    Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ: IV calcitriol in the treatment of refractory osteitis fibrosis of chronic renal failure. N Engl J Med 274: 274, 1989CrossRefGoogle Scholar
  86. 86.
    Kaye M, D’Amons P, Henderson J: Elective total parathyroidectomy without autotransplant in ESRD. Kidney Int 35: 1390, 1989PubMedGoogle Scholar
  87. 87.
    Sulkova S, Valek A: The role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int 34: S198, 1988Google Scholar
  88. 88.
    Acosta JH: Hypertension in chronic renal failure. Kidney Int 22: 702, 1982Google Scholar
  89. 89.
    Cheigh JS, Milite C, Sullivan J, Rubin AL, Stenzl KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19: 453, 1992PubMedGoogle Scholar
  90. 90.
    Sherman RA, Daniel A, Cody RP: The effect of interdialytic weight gain on predialysis blood pressure. Artif Organs 17: 770, 1993PubMedCrossRefGoogle Scholar
  91. 91.
    Ma, KW, Greene EL, Raij L: Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19: 505, 1992PubMedGoogle Scholar
  92. 92.
    Beyerlein C, Saszar G, Hollmann M, Schumacher A: Verapamil in antihypertensive treatment of patients on renal replacement therapy. Eur J Clin Pharmac 39: 35, 1991Google Scholar
  93. 93.
    Abraham PA, Opsahl JA, Kesaviah PR et al.: Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis 16: 438, 1990PubMedGoogle Scholar
  94. 94.
    Battle, DC, Riotte AV, Land G: Delayed hypotensive response to dialysis in hypertensive patients with ESRD. Am J Nephrol 6: 14, 1986Google Scholar
  95. 95.
    United States Renal Data System: USRDS 1993 Annual Data Report. Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1993Google Scholar
  96. 96.
    Ghavamian M, Gutch CF, Kopp KF, Kolff WJ: The sad truth about hemodialysis in diabetics. JAMA 222: 1386, 1972PubMedGoogle Scholar
  97. 97.
    Tzamaloukas, AH, Murphy G, Spalding CT: Diabetic nephropathy: eleven year survival with good quality of life. Clin Nephrol 38: 234, 1992PubMedGoogle Scholar
  98. 98.
    Miles AM, Friedman, EA: Dialytic therapy for diabetic patients with terminal renal failure. Current Opinion in Nephrology and Hypertension 2: 868, 1992Google Scholar
  99. 99.
    Ritz E, Strumpf C, Katz. F, Wing AJ, Quellhorst E: Hypertension and cardiovascular risk factors in hernodialyzyed diabetic patients. Hypertension 7(Suppl 2): S118, 1985Google Scholar
  100. 100.
    Windus DW, Jendrisak MD, Delmez JA: Prosthetic fistula survival and complications in hemodialysis patients. Effects of Diabetes and age. Am J Kidney Dis 19: 448, 1992PubMedGoogle Scholar
  101. 101.
    Weinrauch LA, D’Eliz JA, Gleason RE et al.: Usefulness of left ventricular size and function in predicting survival in chronic hemodialysis patients with diabetes mellitus. Am J Cardiol 7: 300, 1992Google Scholar
  102. 102.
    Ifudu O, Dulin A, Lundin AP, Friedman EA: Diabetics manifest excess weight gain on maintenance hemodialysis. (Abstract) ASAIO J 21: 85, 1992Google Scholar
  103. 103.
    Diaz-Buxo JA, Burges NP, Greenman M, Chandeir JT, Farmer CP, Walker PJ. Comparison of peritoneal and hemodialysis. Int J Artif Organs 7: 257, 1984PubMedGoogle Scholar
  104. 104.
    Berman DH, Friedman EA, Lundin AP: Aggressive ophthalmological management in diabetic ESRD patients: a study of 31 consecutively referred patients. Am J Nephrol 12: 344, 1992PubMedCrossRefGoogle Scholar
  105. 105.
    Vincenti F, Arnaud SB, Recker R et al.: Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25: 677, 1984PubMedGoogle Scholar
  106. 106.
    Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ: Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 316: 292, 1987PubMedCrossRefGoogle Scholar
  107. 107.
    Kjellstrand CM, Whitley K, Comty CM, Shapiro FL: Dialysis in patients with diabetes. Diabetic Nephropathy 2: 5, 1983Google Scholar
  108. 108.
    Hou S: Pregnancy and birth control in dialysis patients. Dial Transpl 23: 22, 1994Google Scholar
  109. 109.
    Souqiyyeh MZ, Huraib SO, Mohd-Saleh AG: Pregnancy in chronic hemodialysis patients in the kingdom of Saudi Arabia. Am J Kidney Dis 19: 235, 1992PubMedGoogle Scholar
  110. 110.
    Hou S: Frequency and outcome of pregnancy in women on dialysis. Am J Kidney Dis 23: 60, 1994PubMedGoogle Scholar
  111. 111.
    Davidson JM: Dialysis, Transplantation and Pregnancy. Am J Kidney Dis 17: 127, 1991Google Scholar
  112. 112. Anon: Are ACE Inhibitors safe in pregnancy? Lancet 2: 482, 1989Google Scholar
  113. 113.
    Hou S, Orlowski J, Pahl M: Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 21: 16, 1993PubMedGoogle Scholar
  114. 114.
    Yasin SY, Beydown SW: Hemodialysis in pregnancy. Obs Gyn Surg 43: 655, 1988CrossRefGoogle Scholar
  115. 115.
    Hou S: Pregnancy in women requiring dialysis for renal failure. Am J Kidney Dis 9: 368, 1987PubMedGoogle Scholar
  116. 116.
    Ko W, Kreiger KH, Isom OW: Cardiopulmonary bypass procedures in dialysis patients. Ann Thorac Surg 55: 677, 1993PubMedCrossRefGoogle Scholar
  117. 117.
    Rostand SG, Kirk KA, Rutsky, EA, Pacifico AD: Results of cardiac bypass graft in ESRD. Am J Kidney Dis 12: 266, 1988PubMedGoogle Scholar
  118. 118.
    Opahl JA, Husebye DG, Helseth HK, Collins AJ: Cardiac bypass surgery in patients on maintenance dialysis: Long term survival. Am J Kidney Dis 12: 271, 1988Google Scholar
  119. 119.
    Pavie A, Mussat T, Valle D et al.: Open heart cardiac surgery in severe renal insufficiency and dialysis patients. Arch Mal Coeur 78: 242, 1985PubMedGoogle Scholar
  120. 120.
    Zawada ET Jr, Stinson JB, Done G: New perspective on coronary artery disease in hemodialysis patients. South Med J 75: 694, 1982PubMedGoogle Scholar
  121. 121.
    Laws KH, Merrill WH, Aammon JW Jr, Prager RL, Bender HW: Cardiac surgery in patients with chronic renal disease. Ann Thorac Surg 42: 152, 1986PubMedCrossRefGoogle Scholar
  122. 122.
    Port FK: The end-stage renal disease program: trends over the past 18 years. Am J Kidney Dis 20: 3, 1992PubMedGoogle Scholar
  123. 123.
    Ismail NI, Hakim RM, Oreopoulos DG, Patrikarea A: Renal replacement therapies in the elderly. Part 1. Hemodialysis and chronic peritoneal dialysis. Am J Kidney Dis 22: 759, 1993PubMedGoogle Scholar
  124. 124.
    Pourchez T, Moriniere P, St Priest A: Outcome of vascular access for hemodialysis in the elderly (< 75 years). Proc Eur Dial Transpl Assoc 27: 160, 1990Google Scholar
  125. 125.
    Hinsdale JG, Lipcowitz GS, Hoover EL: Vascular access in the elderly. Results and perspectives in a geriatric population. Dial Transpl 14: 560, 1985Google Scholar
  126. 126.
    Didlake R, Raju S, Rhodes RS, Bower J: Dialysis access in patients older than 65 years. in Vascular Access for Hemodialysis, edited by Sommer BG, Henry ML, Boston, Precept Press, 1991, p 166Google Scholar
  127. 127.
    Chester AC, Rakowski, Argy WP Jr, Giacalone A, Sheiner GE: Hemodialysis in the eighth and ninth decade of life. Arch Intern Med 139: 1001, 1979PubMedGoogle Scholar
  128. 128.
    Hakim RM, Levin NL: Malnutrition in hemodialysis patients. Am J Kidney Dis 21: 125, 1993PubMedGoogle Scholar
  129. 129.
    Ifudu O, Mayers J, Matthew J, Tan CD, Cambridge A, Friedman EA: Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 5: 29, 1994Google Scholar
  130. 130.
    Banks RA, White HJO, MacKenzie JC, Tribe CR, Harrison PR: Replacement therapy in end stage renal amyloidosis. J Royal Soc Med 78: 593, 1985Google Scholar
  131. 131.
    Port FK, Nissenson AR: Outcome of ESRD in patients with rare causes of renal failure. II Renal or systemic neoplasm. Quart J Med 73: 1161, 1989PubMedGoogle Scholar
  132. 132.
    Moroni G, Banfi I: Chronic Dialysis in patients with systemic amyloidosis. The experience in Northern Italy. Clin Nephrol 38: 81, 1992PubMedGoogle Scholar
  133. 133.
    Gertz MA, Kyle RA, O’Falloon WM: Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 152: 2245, 1992PubMedGoogle Scholar
  134. 134.
    Hashmoni M, Shapir Y, Chaimovitz C, Better OS, Schamek A: Blood access for hemodialysis in patients with end stage renal amyloid. Dial Transpl 11: 307, 1982Google Scholar
  135. 135.
    Martinez VA, Garcia C, Carreras M, Renert L, Olive JA: ESRD in systemic amyloidosis. Clinical course and outcome on dialysis. Am J Nephrol 10: 283, 1990Google Scholar
  136. 136.
    Ylinken K, Gronhagen C, Honkamen E, Ekstrand A, Metsarinne K, Kuhlback B: Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transpl 7: 908, 1992Google Scholar
  137. 137.
    Rosansky SJ, Richards FW: Use of peritoneal dialysis in the treatment of patients with renal failure and paraproteinemia. Am J Nephrol 5: 361, 1985PubMedGoogle Scholar
  138. 138.
    Shapiro W, Chou SY, Porush JG: Nephrectomy for intractable proteinuria secondary to severe nephrotic syndrome. Abs Am Soc Nephrol 8: 824, 1975Google Scholar
  139. 139.
    Avram MM, Lapinid N, Lipner H: Medical nephrectomy. The use of metallic salts in uncontrollable massive nephrotic syndrome. Trans Am Soc Artif Intern Organs 22: 431, 1976PubMedGoogle Scholar
  140. 140.
    Mallick NP: Dialysis in the management of the renal failure of myeloma. Quart J Med 270: 871, 1989Google Scholar
  141. 141.
    Brown JH, Maxwell AP, Bruce I, Murphy BG, Doherty CC: Renal replacement therapy in multiple myeloma and systemic amyloidosis. Irish J Med Sci 162: 213, 1993PubMedCrossRefGoogle Scholar
  142. 142.
    Iggo N, Palmer ABD, Severn A et al.: Chronic dialysis in patients with multiple myeloma and renal failure. A worthwhile treatment. Quart J Med 270: 903, 1989Google Scholar
  143. 143.
    Cosio FG, Pence TV, Shapiro FL, Kjellstrand CM: Severe renal failure in multiple myeloma. Clin Nephrol 15: 206, 1981PubMedGoogle Scholar
  144. 144.
    Lazarus HM, Adelstein DJ, Herzig RH, Smith MC: Long term survival of patients with multiple myeloma and acute renal failure at presentation. Am J Kidney Dis 2: 521, 1983PubMedGoogle Scholar
  145. 145.
    Randall RE, Williamson WC, Mullinax F, Tung MF, Still JS: Manifestations of systemic light chain deposition. Am J Med 60: 293, 1976PubMedGoogle Scholar
  146. 146.
    Ruedin P, Pechere Bertschi A, Chapuis B, Benedit P, Leski M: Safety and efficacy of recombinant human erythropoietin treatment of anemia associated with multiple myeloma in hemodialyzed patients. Nephrol Dial Transpl 8: 315, 1993Google Scholar
  147. 147.
    Caillette A, Barreto S, Gimenez E, Labeeuw M, Zech P: Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis? Clin Nephrol 40: 176, 1993PubMedGoogle Scholar
  148. 148.
    Ellis D, Avner ED: Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplant. Clin Nephrol 25: 295, 1986PubMedGoogle Scholar
  149. 149.
    Marcus RG, Messana J, Swartz R: Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 93: 35, 1992PubMedGoogle Scholar
  150. 150.
    Langley, PG, Keays R, Hughes Rd, Forbes A, Delvos U, Williams R: Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 14: 251, 1991PubMedGoogle Scholar
  151. 151.
    Gotlieb L, Servadis C: Ascites in patients undergoing maintenance hemodialysis. Am J Med 101: 161, 1976Google Scholar
  152. 152.
    Arismendi GS, Izard MW, Harnptom WR, Maher JF: The clinical spectrum of ascites associated with maintenance dialysis. Am J Med 60: 46, 1976PubMedGoogle Scholar
  153. 153.
    Kearns PJ, Polhemus RJ, Oakes D, Rabkin R: Hepatorenal syndrome managed with hemodialysis, then reversed by peritoneovenous shunting. J Clin Gastroenterol 7: 341, 1985PubMedGoogle Scholar
  154. 154.
    Ponce P, Moreira P: Water immersion in an anuric cirrhotic patient. Nephron 43: 144, 1986PubMedGoogle Scholar
  155. 155.
    Okada K, Takahashi S, Higuch T, Maega H: Long term effect of intravenous reinfusion of unmodified autogenous peritoneal fluid combined with hemodialysis in a patient with dialysis related ascites. Nephron 65: 474, 1993PubMedGoogle Scholar
  156. 156.
    Reiser IA, Shapiro WB, Porush JG: The incidence and epidemiology of human immunodeficiency virus infection in 320 patients treated in an inner-city hemodialysis Unit. Am J Kidney Dis 16: 26, 1990PubMedGoogle Scholar
  157. 157.
    Ribot S, Dean D, Goldblat M, Saavedra M: Prognosis of HIV positive dialysis patients. Kidney Int 37: 325, 1990Google Scholar
  158. 158.
    Zara, AC, Berlyne GM, Barth RH: Prolonged survival in an AIDS patients with ESRD. Kidney Int 37: 325, 1990Google Scholar
  159. 159.
    Schoenfeld P, Feduska, NJ: Acquired immunodeficiency syndrome and renal disease: Report of the National Kidney Foundation-NIH Task Force in AIDS arid kidney disease. Am J Kidney Dis 16: 14, 1990PubMedGoogle Scholar
  160. 160. Recommendation for prevention of HIV transmission in health care workers. MMWR 36 (Suppl 23): 1S, 1987Google Scholar
  161. 161.
    Rao TKS: Acquired immunodeficiency syndrome, HIV virus infection and dialysis. in International Yearbook of Nephrology, edited by Andreucci VE, Fein LG, Boston, Kluwer Academic Publishers, 1991, p 199Google Scholar
  162. 162.
    Nissenson AR, Port FK: Outcome of end-stage renal disease in patients with rare causes of renal failure III. Systemic vascular disorders. Quart J Med 14: 63, 1990Google Scholar
  163. 163.
    Nossent HC, Swaak TT, Berden JH: Systemic lupus erythematosus: Analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or CAPD. Am J Med 89: 169, 1990PubMedGoogle Scholar
  164. 164.
    Cheigh JS, Stenzel KH: End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 21: 2, 1993PubMedGoogle Scholar
  165. 165.
    Hernandez, JJ, Bernis C, Paraiso V, Barril G, Alverez V, Traver JA: Development of systemic lupus erythematosus in a patients on hemodialysis. Am J Nephrol 112: 105, 1992Google Scholar
  166. 166.
    Stock GG, Krahe NK: Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis. Adv Peril Dial 9: 147, 1993Google Scholar
  167. 167.
    Sitter T, Spannagl M, Schiffi H: Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 65: 79, 1992PubMedGoogle Scholar
  168. 168.
    Coplon NS, Siegel R, Fries J: Hemodialysis in end stage lupus nephritis. Trans Am Soc Artif Intern Organs 19: 302, 1973PubMedGoogle Scholar
  169. 169.
    Prowars DR: Chronic renal failure in sickle cell anemia: Risk factors, clinical course and Mortality. Ann Intern Med 115: 614, 1991Google Scholar
  170. 170.
    Nissenson AR, Port FK: Outcome of ESRD in Patients with rare causes of renal failure. 1. Inherited arid Metabolic Disorders. Quart J Med 73: 1055, 1989PubMedGoogle Scholar
  171. 171.
    Singhal PC, Lynn RI, Scharschmidt LA: Priapism and Dialysis. Am J Nephrol 6: 358, 1986PubMedGoogle Scholar
  172. 172.
    Tomson CRV: ESRD in sickle cell anemia. Future directions. Postgraduate Med J 68: 775, 1992Google Scholar
  173. 173.
    Gonzalez-Carrillo M, Rudge CJ, Parsons V, Bewick M, White JM: Renal transplantation in sickle cell disease. Clin Nephrol 18: 209, 1982PubMedGoogle Scholar
  174. 174.
    Steinberg MH: Erthyropoietin for anemia of renal failure in sickle cell anemia. N Engl J Med 324: 1369, 1991PubMedCrossRefGoogle Scholar
  175. 175.
    Rogers SD, MacDougall JC, Thuraisinghen RC, Raine AEG: Erythropoietin in anemia of renal failure in sickle cell anemia. N Engl J Med 325: 1175, 1991CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Barbara G. Delano
    • 1
  1. 1.Department of MedicineState University of New York Health Science Center BrooklynBrooklynUSA

Personalised recommendations